It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Canine atopic dermatitis (CAD) is a prevalent inflammatory skin disease of dogs worldwide. Certain breeds such as the West Highland White Terriers (WHWT) are predisposed to suffer from CAD. Microbial dysbiosis is known to play a significant role in the pathogenesis of the disease, which is similar to its human counterpart, atopic dermatitis (AD). To date, no large cohort-study has been conducted in a predisposed dog breed to study the impact of the early-life microbiota on the development of CAD, as well as the possible implication of factors such as hygiene and access to the outdoors. In this study skin samples of 143 WHWT, including 109 puppies up to three weeks old and 34 parent dogs, from 17 breeders, were subjected to 16S rRNA gene and ITS2 amplicon sequencing to disclose the bacterial and fungal oral and skin microbiota, respectively. The oral samples served as a control group to confirm differences between haired and mucosal surfaces. The cutaneous microbiota differed between sample sites and age of the dogs. The season of sampling, geographical origin as well as hygiene status of the household and the access to the outdoors shaped the skin microbiota of the puppies significantly. However, we found that the individual early-life microbiota did not predispose for the later development of CAD.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Bern, Switzerland (GRID:grid.5734.5) (ISNI:0000 0001 0726 5157); Bacteriology and Mycology Unit, Faculty of Veterinary Medicine, Norwegian University of Life Sciences, Oslo, Norway (GRID:grid.19477.3c) (ISNI:0000 0004 0607 975X)
2 Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
3 Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Bern, Switzerland (GRID:grid.5734.5) (ISNI:0000 0001 0726 5157)
4 Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Bern, Switzerland (GRID:grid.5734.5) (ISNI:0000 0001 0726 5157); Gnubiotics Sciences SA, Microbiome Research, StartLab/Biopôle, Bat SE-B, Epalinges, Switzerland (GRID:grid.5734.5)
5 Department of Preventive Dentistry, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (GRID:grid.424087.d) (ISNI:0000 0001 0295 4797)